BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCT
4251
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $1.11M | ﹤0.01% |
50,277
-105,544
| -68% | -$2.35M |
|
4252
Actinium Pharmaceuticals
ATNM
$26.3M
| $1.11M | ﹤0.01% |
231,816
+866
| +0.4% | +$4.92K |
|
|
TIO
4253
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $1.11M | ﹤0.01% |
1,958,534
-263,032
| -12% | -$164K |
|
4254
Retractable Technologies
RVP
$19.8M
| $1.11M | ﹤0.01% |
290,199
-795,154
| -73% | -$3.25M |
|
4255
QuickLogic
QUIK
$232M
| $1.11M | ﹤0.01% |
130,724
-1,726
| -1% | -$10.7K |
|
4256
Quince Therapeutics
QNCX
$22.9M
| $1.11M | ﹤0.01% |
2,499
-4,521
| -64% | -$3.2M |
|
4257
VolitionRx Ltd
VNRX
$8.65M
| $1.11M | ﹤0.01% |
27,026
-367
| -1% | -$18.5K |
|
4258
Research Frontiers
REFR
$14M
| $1.1M | ﹤0.01% |
631,082
+460
| +0.1% | +$833 |
|
|
INTZ
4259
DELISTED
INTRUSION INC NEW
INTZ
| $1.09M | ﹤0.01% |
278,293
-1,895
| -0.7% | -$7.41K |
|
|
ISD
4260
PGIM High Yield Bond Fund
ISD
$415M
| $1.08M | ﹤0.01% |
+88,177
| New | +$1.18M |
|
4261
SOPHiA GENETICS
SOPH
$476M
| $1.08M | ﹤0.01% |
299,084
| – | – |
|
|
IMMP
4262
Immutep
IMMP
$56.3M
| $1.08M | ﹤0.01% |
532,752
-11,948
| -2% | -$29.5K |
|
4263
Alpha Pro Tech
APT
$50.4M
| $1.08M | ﹤0.01% |
241,921
-1,867
| -0.8% | -$7.95K |
|
|
FLNT
4264
Fluent
FLNT
$102M
| $1.08M | ﹤0.01% |
150,648
-355,797
| -70% | -$2.97M |
|
4265
American Coastal Insurance
ACIC
$515M
| $1.07M | ﹤0.01% |
687,892
-1,073,147
| -61% | -$2.28M |
|
4266
Lee Enterprises
LEE
$172M
| $1.06M | ﹤0.01% |
56,014
-996
| -2% | -$21.8K |
|
|
CFMS
4267
DELISTED
Conformis, Inc. Common Stock
CFMS
| $1.06M | ﹤0.01% |
119,906
+305
| +0.3% | +$3.48K |
|
4268
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
| $1.06M | ﹤0.01% |
22,096
+21,390
| +3,030% | +$1.03M |
|
|
MTEM
4269
DELISTED
Molecular Templates, Inc.
MTEM
| $1.05M | ﹤0.01% |
77,173
-111,610
| -59% | -$2.61M |
|
|
LTRPA
4270
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.05M | ﹤0.01% |
1,389,583
-3,633,532
| -72% | -$4.67M |
|
4271
Criteo S.A. Ordinary Shares
CRTO
$1.1B
| $1.05M | ﹤0.01% |
43,004
+2,584
| +6% | +$65.7K |
|
4272
iBio
IBIO
$69.5M
| $1.05M | ﹤0.01% |
7,921
-22,520
| -74% | -$3.39M |
|
4273
Capricor Therapeutics
CAPR
$223M
| $1.04M | ﹤0.01% |
298,881
-3,638
| -1% | -$12.9K |
|
|
FARM
4274
DELISTED
Farmer Brothers
FARM
| $1.03M | ﹤0.01% |
220,403
-3,775
| -2% | -$21.3K |
|
4275
Security National Financial
SNFCA
$244M
| $1.03M | ﹤0.01% |
148,400
-2,222
| -1% | -$16.2K |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.